# Cogent Communications Holdings, Inc.: financial statements, quarterly

CCOI · Nasdaq · CIK 1158324 · [Communication](/sectors/communication.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ccoi.md) · [Financials](/companies/ccoi/financials.md) · [Filings](/companies/ccoi/filings.md) · [Insiders](/companies/ccoi/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ccoi/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [275](/filings/0001410578-24-001788.md) | [272 d](/filings/0001104659-26-017968.md) | [266](/filings/0001410578-25-001105.md) | [260](/filings/0001410578-25-001593.md) | [257](/filings/0001104659-25-107544.md) | [252 d](/filings/0001104659-26-017968.md) | [247](/filings/0001104659-26-054611.md) | [246](/filings/0001104659-26-091790.md) | [242](/filings/0001104659-25-107544.md) | [241 d](/filings/0001104659-26-017968.md) | [239](/filings/0001104659-26-054611.md) | [236](/filings/0001104659-26-091790.md) |
| Cost of revenue | $m | [174](/filings/0001410578-24-001788.md) | [174 d](/filings/0001104659-26-017968.md) | [169](/filings/0001410578-25-001105.md) | [156](/filings/0001410578-25-001593.md) | [162](/filings/0001104659-25-107544.md) | [155 d](/filings/0001104659-26-017968.md) | [137](/filings/0001104659-26-054611.md) | [137](/filings/0001104659-26-091790.md) | [132](/filings/0001104659-25-107544.md) | [128 d](/filings/0001104659-26-017968.md) | [129](/filings/0001104659-26-054611.md) | [125](/filings/0001104659-26-091790.md) |
| Selling, general and administrative | $m | [65.3](/filings/0001410578-24-001788.md) | [81.3 d](/filings/0001104659-26-017968.md) | [76.7](/filings/0001410578-25-001105.md) | [68.3](/filings/0001410578-25-001593.md) | [67.7](/filings/0001104659-25-107544.md) | [63.1 d](/filings/0001104659-26-017968.md) | [73.9](/filings/0001104659-26-054611.md) | [64.9](/filings/0001104659-26-091790.md) | [70.4](/filings/0001104659-25-107544.md) | [65.2 d](/filings/0001104659-26-017968.md) | [72.3](/filings/0001104659-26-054611.md) | [72.1](/filings/0001104659-26-091790.md) |
| Operating income | $m | [(50.6)](/filings/0001410578-24-001788.md) | [(68.5) d](/filings/0001104659-26-017968.md) | [(59.4)](/filings/0001410578-25-001105.md) | [(47.1)](/filings/0001410578-25-001593.md) | [(57.8)](/filings/0001104659-25-107544.md) | [(33.2) d](/filings/0001104659-26-017968.md) | [(40.3)](/filings/0001104659-26-054611.md) | [(31.5)](/filings/0001104659-26-091790.md) | [(18.1)](/filings/0001104659-25-107544.md) | [(11.2) d](/filings/0001104659-26-017968.md) | [(13.5)](/filings/0001104659-26-054611.md) | [119](/filings/0001104659-26-091790.md) |
| Interest expense | $m | [24.2](/filings/0001410578-23-002293.md) | [21.5 d](/filings/0001410578-25-000226.md) | [23.0](/filings/0001410578-24-000677.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [(13.6)](/filings/0001410578-24-001788.md) | [(20.4) d](/filings/0001104659-26-017968.md) | [(19.1)](/filings/0001410578-25-001105.md) | [(7.9)](/filings/0001410578-25-001593.md) | [(16.9)](/filings/0001104659-25-107544.md) | [(11.7) d](/filings/0001104659-26-017968.md) | [(18.2)](/filings/0001104659-26-054611.md) | [(16.7)](/filings/0001104659-26-091790.md) | [(11.1)](/filings/0001104659-25-107544.md) | [(16.8) d](/filings/0001104659-26-017968.md) | [(11.4)](/filings/0001104659-26-054611.md) | [16.5](/filings/0001104659-26-091790.md) |
| Net income | $m | [(56.7)](/filings/0001410578-24-001788.md) | [200 d](/filings/0001104659-26-017968.md) | [(65.3)](/filings/0001410578-25-001105.md) | [(32.3)](/filings/0001410578-25-001593.md) | [(63.1)](/filings/0001104659-25-107544.md) | [(43.3) d](/filings/0001104659-26-017968.md) | [(52.0)](/filings/0001104659-26-054611.md) | [(57.8)](/filings/0001104659-26-091790.md) | [(41.5)](/filings/0001104659-25-107544.md) | [(30.8) d](/filings/0001104659-26-017968.md) | [(39.5)](/filings/0001104659-26-054611.md) | [66.6](/filings/0001104659-26-091790.md) |
| Diluted EPS | $ per share | [(1.20)](/filings/0001410578-24-001788.md) | not reported | [(1.38)](/filings/0001410578-25-001105.md) | [(0.68)](/filings/0001410578-25-001593.md) | [(1.33)](/filings/0001104659-25-107544.md) | not reported | [(1.09)](/filings/0001104659-26-054611.md) | [(1.21)](/filings/0001104659-26-091790.md) | [(0.87)](/filings/0001104659-25-107544.md) | not reported | [(0.83)](/filings/0001104659-26-054611.md) | [1.38](/filings/0001104659-26-091790.md) |
| Basic EPS | $ per share | [(1.20)](/filings/0001410578-24-001788.md) | not reported | [(1.38)](/filings/0001410578-25-001105.md) | [(0.68)](/filings/0001410578-25-001593.md) | [(1.33)](/filings/0001104659-25-107544.md) | not reported | [(1.09)](/filings/0001104659-26-054611.md) | [(1.21)](/filings/0001104659-26-091790.md) | [(0.87)](/filings/0001104659-25-107544.md) | not reported | [(0.83)](/filings/0001104659-26-054611.md) | [1.39](/filings/0001104659-26-091790.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic, us-gaap:NetIncomeLoss, us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [110](/filings/0001410578-23-002293.md) | [75.1](/filings/0001410578-25-000226.md) | [118](/filings/0001410578-24-000677.md) | [384](/filings/0001410578-24-001206.md) | [279](/filings/0001410578-24-001788.md) | [198](/filings/0001104659-26-017968.md) | [154](/filings/0001410578-25-001105.md) | [214](/filings/0001410578-25-001593.md) | [147](/filings/0001104659-25-107544.md) | [149](/filings/0001104659-26-091790.md) | [140](/filings/0001104659-26-054611.md) | [184](/filings/0001104659-26-091790.md) |
| Current assets | $m | [581](/filings/0001410578-23-002293.md) | [514](/filings/0001410578-25-000226.md) | [473](/filings/0001410578-24-000677.md) | [689](/filings/0001410578-24-001206.md) | [569](/filings/0001410578-24-001788.md) | [482](/filings/0001104659-26-017968.md) | [423](/filings/0001410578-25-001105.md) | [561](/filings/0001410578-25-001593.md) | [480](/filings/0001104659-25-107544.md) | [451](/filings/0001104659-26-091790.md) | [430](/filings/0001104659-26-054611.md) | [606](/filings/0001104659-26-091790.md) |
| Total assets | $m | [2,962](/filings/0001410578-23-002293.md) | [3,212](/filings/0001410578-25-000226.md) | [3,145](/filings/0001410578-24-000677.md) | [3,344](/filings/0001410578-24-001206.md) | [3,204](/filings/0001410578-24-001788.md) | [3,173](/filings/0001104659-26-017968.md) | [3,121](/filings/0001410578-25-001105.md) | [3,271](/filings/0001410578-25-001593.md) | [3,148](/filings/0001104659-25-107544.md) | [3,100](/filings/0001104659-26-091790.md) | [3,057](/filings/0001104659-26-054611.md) | [3,104](/filings/0001104659-26-091790.md) |
| Current liabilities | $m | [356](/filings/0001410578-23-002293.md) | [373](/filings/0001410578-25-000226.md) | [421](/filings/0001410578-24-000677.md) | [313](/filings/0001410578-24-001206.md) | [281](/filings/0001410578-24-001788.md) | [253](/filings/0001104659-26-017968.md) | [283](/filings/0001410578-25-001105.md) | [243](/filings/0001410578-25-001593.md) | [238](/filings/0001104659-25-107544.md) | [221](/filings/0001104659-26-091790.md) | [226](/filings/0001104659-26-054611.md) | [960](/filings/0001104659-26-091790.md) |
| Total liabilities | $m | [2,520](/filings/0001410578-23-002293.md) | [2,602](/filings/0001410578-25-000226.md) | [2,645](/filings/0001410578-24-000677.md) | [2,929](/filings/0001410578-24-001206.md) | [2,881](/filings/0001410578-24-001788.md) | [2,950](/filings/0001104659-26-017968.md) | [2,978](/filings/0001410578-25-001105.md) | [3,224](/filings/0001410578-25-001593.md) | [3,187](/filings/0001104659-25-107544.md) | [3,164](/filings/0001104659-26-091790.md) | [3,161](/filings/0001104659-26-054611.md) | [3,138](/filings/0001104659-26-091790.md) |
| Long-term debt | $m | not reported | [950](/filings/0001410578-24-000091.md) | not reported | not reported | not reported | [1,456](/filings/0001410578-25-000226.md) | not reported | not reported | not reported | [1,730](/filings/0001104659-26-017968.md) | not reported | not reported |
| Shareholders' equity | $m | [442](/filings/0001410578-24-001788.md) | [610](/filings/0001104659-26-017968.md) | [501](/filings/0001410578-25-001593.md) | [416](/filings/0001104659-25-107544.md) | [324](/filings/0001104659-25-107544.md) | [223](/filings/0001104659-26-091790.md) | [143](/filings/0001104659-26-091790.md) | [46.7](/filings/0001104659-26-091790.md) | [(39.2)](/filings/0001104659-25-107544.md) | [(63.8)](/filings/0001104659-26-091790.md) | [(104)](/filings/0001104659-26-091790.md) | [(34.1)](/filings/0001104659-26-091790.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(52.4) d](/filings/0001410578-24-001788.md) | [(48.7) d](/filings/0001104659-26-017968.md) | [19.2](/filings/0001410578-25-001105.md) | [(22.2) d](/filings/0001410578-25-001593.md) | [(20.2) d](/filings/0001104659-25-107544.md) | [14.5 d](/filings/0001104659-26-017968.md) | [36.4](/filings/0001104659-26-054611.md) | [(44.0) d](/filings/0001104659-26-091790.md) | [3.1 d](/filings/0001104659-25-107544.md) | [(6.0) d](/filings/0001104659-26-017968.md) | [14.8](/filings/0001104659-26-054611.md) | [3.2 d](/filings/0001104659-26-091790.md) |
| Capital expenditure | $m | [25.4 d](/filings/0001410578-24-001788.md) | [43.6 d](/filings/0001104659-26-017968.md) | [40.9](/filings/0001410578-25-001105.md) | [48.8 d](/filings/0001410578-25-001593.md) | [59.2 d](/filings/0001104659-25-107544.md) | [46.1 d](/filings/0001104659-26-017968.md) | [58.1](/filings/0001104659-26-054611.md) | [56.2 d](/filings/0001104659-26-091790.md) | [36.3 d](/filings/0001104659-25-107544.md) | [37.0 d](/filings/0001104659-26-017968.md) | [46.2](/filings/0001104659-26-054611.md) | [38.5 d](/filings/0001104659-26-091790.md) |
| Dividends paid | $m | [45.1 d](/filings/0001410578-24-001788.md) | [46.4 d](/filings/0001104659-26-017968.md) | [0.5](/filings/0001410578-25-001105.md) | [93.3 d](/filings/0001410578-25-001593.md) | [47.2 d](/filings/0001104659-25-107544.md) | [48.4 d](/filings/0001104659-26-017968.md) | [49.1](/filings/0001104659-26-054611.md) | [49.6](/filings/0001104659-26-091790.md) | [49.1 d](/filings/0001104659-25-107544.md) | [2.3 d](/filings/0001104659-26-017968.md) | [1.3](/filings/0001104659-26-054611.md) | [2.3](/filings/0001104659-26-091790.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | [0.0 d](/filings/0001104659-25-107544.md) | [0.0 d](/filings/0001104659-26-017968.md) | not reported | [11.5](/filings/0001410578-25-001593.md) | [5.2](/filings/0001104659-25-107544.md) | [0.0 d](/filings/0001104659-26-017968.md) | [106](/filings/0001104659-26-054611.md) | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends, us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [46.7](/filings/0001410578-23-002293.md) | [47.4](/filings/0001410578-24-000677.md) | [47.5](/filings/0001410578-24-001206.md) | [47.2](/filings/0001410578-24-001788.md) | [47.4](/filings/0001410578-25-001105.md) | [47.5](/filings/0001410578-25-001593.md) | [47.4](/filings/0001104659-25-107544.md) | [47.7](/filings/0001104659-26-054611.md) | [47.6](/filings/0001104659-26-091790.md) | [47.6](/filings/0001104659-25-107544.md) | [47.8](/filings/0001104659-26-054611.md) | [48.4](/filings/0001104659-26-091790.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 51,215,736 at 2026-07-31, from the cover of the [10-Q filed 2026-08-06](/filings/0001104659-26-091790.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:34 ET. No prices; not investment advice.